Assessment of left ventricular diastolic dysfunction (LVDD) and filling pressure is standard in echocardiography but remains time- and expertise-dependent. We evaluated the performance and prognostic significance of an artificial intelligence (AI)-enabled echocardiography for LVDD grading.
An AI model was...
R. Loutati, M. Fiman, A. Amshalom et al.· European Heart Journal· 0 citations
Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic disorder defined by the overlapping burden of heart failure (HF), chronic kidney disease (CKD), diabetes, and obesity. Although sex differences in cardiovascular disease are increasingly recognized, sex-specific patterns of mortality and renal progressi...
D. Hochstein, R. Loutati, V. Copeland et al.· European Heart Journal· 0 citations
Patients with advanced chronic kidney disease (CKD) and heart failure (HF) are systematically underrepresented in clinical trials despite comprising a substantial proportion of real-world HF populations [1]. Whether contemporary care has translated into improved outcomes in this high-risk group particularly among...
D. Hochstein, D. Sternik, V. Copeland et al.· European Heart Journal· 0 citations
Left ventricular hypertrophy is a hallmark of adverse remodeling in heart failure (HF), yet commonly used echocardiographic measures provide limited insight into sex-specific risk. Interventricular septal (IVS) thickness is routinely measured, but its independent prognostic value and potential sex-related differe...
A. Kaplan, V. Copeland, R. Loutati et al.· European Heart Journal· 0 citations
In patients with late-stage metabolic syndrome, CKD identifies a high-risk subgroup with a graded increase in mortality and dialysis risk compared with eGFR ≥60, and the heightened dialysis risk remained pronounced after accounting for competing death.
D. Hochstein, R. Loutati, V. Copeland et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
